Flexible targeting of ErbB dimers that drive tumorigenesis by using genetically engineered T cells.

Molecular Medicine
David M DaviesJohn Maher

Abstract

Pharmacological targeting of individual ErbB receptors elicits antitumor activity, but is frequently compromised by resistance leading to therapeutic failure. Here, we describe an immunotherapeutic approach that exploits prevalent and fundamental mechanisms by which aberrant upregulation of the ErbB network drives tumorigenesis. A chimeric antigen receptor named T1E28z was engineered, in which the promiscuous ErbB ligand, T1E, is fused to a CD28 + CD3ζ endodomain. Using a panel of ErbB-engineered 32D hematopoietic cells, we found that human T1E28z⁺ T cells are selectively activated by all ErbB1-based homodimers and heterodimers and by the potently mitogenic ErbB2/3 heterodimer. Owing to this flexible targeting capability, recognition and destruction of several tumor cell lines was achieved by T1E28⁺ T cells in vitro, comprising a wide diversity of ErbB receptor profiles and tumor origins. Furthermore, compelling antitumor activity was observed in mice bearing established xenografts, characterized either by ErbB1/2 or ErbB2/3 overexpression and representative of insidious or rapidly progressive tumor types. Together, these findings support the clinical development of a broadly applicable immunotherapeutic approach in which the p...Continue Reading

Associated Clinical Trials

References

Jun 17, 1998·Proceedings of the National Academy of Sciences of the United States of America·L M WangJ H Pierce
Mar 22, 2003·Experimental Cell Research·Carlos L Arteaga
Jul 11, 2003·Proceedings of the National Academy of Sciences of the United States of America·Thomas HolbroNancy E Hynes
Aug 12, 2003·International Journal of Radiation Oncology, Biology, Physics·Ke LiangZhen Fan
Feb 24, 2005·Seminars in Oncology·A Craig LockhartJordan D Berlin
Mar 24, 2005·Cancer Metastasis Reviews·Susanne J RogersSuzanne A Eccles
Jun 6, 2006·International Journal of Radiation Oncology, Biology, Physics·Joseph N ContessaRupert K Schmidt-Ullrich
Jul 11, 2006·Nature Reviews. Molecular Cell Biology·Ami Citri, Yosef Yarden
Jul 25, 2007·Cancer Immunology, Immunotherapy : CII·Helga BernhardChristian Peschel
Aug 19, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Christoph A RitterCarlos L Arteaga
Mar 21, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Scott WilkieJohn Maher
Jun 10, 2008·Cancer Immunology, Immunotherapy : CII·Elizabeth A MittendorfGeorge E Peoples
Jun 10, 2008·Anti-cancer Agents in Medicinal Chemistry·S DalleC Dumontet
Jun 24, 2008·The Journal of Clinical Investigation·Marta GuixJeffrey A Engelman
Aug 13, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Roberto BiancoGiampaolo Tortora
Sep 10, 2008·Experimental Cell Research·Sarah Morgan, Jennifer R Grandis
Feb 12, 2009·Current Opinion in Cell Biology·Nancy E Hynes, Gwen MacDonald
Jun 19, 2009·Nature Reviews. Cancer·José Baselga, Sandra M Swain
Sep 18, 2009·Trends in Cell Biology·Andrea Z LaiMorag Park
Dec 17, 2009·The Cancer Journal·Michel Sadelain
Jan 13, 2010·Experimental Cell Research·Tim J Kruser, Deric L Wheeler
Feb 10, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Harold J BursteinRajendra Badwe
Feb 11, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Peter HammarstenAnders Bergh
Feb 11, 2010·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·D Mark HickinsonDonald Ogilvie
Feb 25, 2010·Molecular Therapy : the Journal of the American Society of Gene Therapy·Richard A MorganSteven A Rosenberg
Apr 8, 2010·Archivum Immunologiae Et Therapiae Experimentalis·David Marc Davies, John Maher
Jul 22, 2010·Cancer Biology & Therapy·J Spencer LilesAndrey Frolov
Sep 4, 2010·Seminars in Cell & Developmental Biology·John FoleyDavid J Riese
Mar 10, 2011·Proceedings of the National Academy of Sciences of the United States of America·Joan T GarrettCarlos L Arteaga
Apr 21, 2011·Journal of Clinical Immunology·Ana Caterina Parente-PereiraJohn Maher
May 24, 2011·Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry·Maitreyee K JathalParamita M Ghosh
Sep 29, 2011·Cellular Signalling·Lene Melsæther GrøvdalBo van Deurs

❮ Previous
Next ❯

Citations

Oct 17, 2015·Immunopharmacology and Immunotoxicology·Doraid AlrifaiJohn Maher
Mar 24, 2016·Nature Reviews. Clinical Oncology·Hollie J JacksonRenier J Brentjens
Jun 13, 2015·Immunotherapy·Milena KalaitsidouDavid Edward Gilham
Mar 26, 2015·Immunotherapy·Lynsey M Whilding, John Maher
Dec 18, 2013·Immunological Reviews·Marco Ruella, Michael Kalos
Dec 18, 2013·Immunological Reviews·Gianpietro DottiMalcolm K Brenner
Jan 28, 2017·Molecular Therapy : the Journal of the American Society of Gene Therapy·Lynsey M WhildingJohn Maher
Jan 10, 2018·The Journal of Immunology : Official Journal of the American Association of Immunologists·Shivani Srivastava, Stanley R Riddell
Dec 7, 2017·Oncoimmunology·Thivyan ThayaparanJohn Maher
Nov 14, 2015·Molecular Oncology·Lynsey M Whilding, John Maher
Mar 16, 2018·Nature Communications·Nia Emami-ShahriSophie Papa
Jun 1, 2017·American Society of Clinical Oncology Educational Book·Oladapo YekuRenier J Brentjens
Sep 26, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sjoukje J C van der StegenJohn Maher
Jun 20, 2020·Scandinavian Journal of Immunology·Emmanuelle BenardSébastien Wälchli
Feb 20, 2016·Archives of Pharmacal Research·Mi-Gyeong KimYu-Kyoung Oh
Jul 19, 2017·Cancers·Praveen Sridhar, Fabio Petrocca
Mar 16, 2018·Biochemical Society Transactions·Lisa M EbertMichael P Brown
Jul 31, 2013·The Journal of Immunology : Official Journal of the American Association of Immunologists·Ana C Parente-PereiraJohn Maher
Feb 13, 2018·Biotechnology & Genetic Engineering Reviews·Niaz MuhammadHaibin Xia
Aug 1, 2019·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Lorraine SpringuelFrédéric F Lehmann
Mar 5, 2019·Frontiers in Immunology·Christopher DeRenzo, Stephen Gottschalk
Jan 2, 2020·International Journal of Molecular Sciences·Hannah E Hughes-ParryMisty R Jenkins
Dec 22, 2016·Immunotherapy·Ksenia BezverbnayaJonathan L Bramson
Mar 16, 2019·Current Treatment Options in Oncology·Hannan A Qureshi, Sylvia M Lee
Sep 8, 2019·Cellular Immunology·Daniel FeinbergYubin Kang
Jan 23, 2021·RSC Medicinal Chemistry·Vítor YangNuno Vale
May 6, 2021·Cell Reports Medicine·Paris KostiJames N Arnold
May 25, 2021·Medicinal Research Reviews·Heleen HanssensNick Devoogdt
May 27, 2021·Expert Opinion on Drug Discovery·Caroline M Hull, John Maher
May 28, 2021·Biologics : Targets & Therapy·Maya GloverJohn Maher
Jun 12, 2021·Frontiers in Neuroscience·Luke MaggsSoldano Ferrone
Aug 2, 2021·Cancer Cell International·Gang ChengShibing Wang
Aug 18, 2021·STAR Protocols·Paris KostiJames N Arnold
Sep 27, 2020·Molecular Therapy : the Journal of the American Society of Gene Therapy·Jessica WagnerStephen Gottschalk

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.